376270 — HEM Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for HEM Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,057	12,202	8,151	11,274
Net Total Accounts Receivable
Net Total Receivables	69.5	924	1,953	4,473
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15,722	22,964	10,963	17,306
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,527	9,554	14,982	17,628
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	27,007	34,835	27,824	36,862
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,462	13,504	8,610	9,077
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	5,727	14,600	10,447	10,744
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	21,281	20,235	17,377	26,118
Total Liabilities & Shareholders' Equity	27,007	34,835	27,824	36,862
Total Common Shares Outstanding